Kidney Transplant Market by Country (United States, Germany, France, Italy, United Kingdom, Japan, Argentina, Mexico, Spain, Brazil) Analysis and Forecast to 2021

The following market research report is for the ever-changing, ever-evolving Kidney Transplant market in Global. The current report is the most updated report you will find on the Global Kidney Transplant market. Using 2020 and preceding years as the base, the report carries accurate data on the forecasts from the year 2020 to 2025. From current statistics, facts and figures of the industry to the future prospects, business strategies and revenue of the biggest operators in the industry, you will find all the data that’s been thoroughly cross-checked and verified by the finest authors and researchers. Keyplayers and more - all the biggest companies operating in the Global Kidney Transplant market have been profiled and analyzed in the report as well.

Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease (ESRD) patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the number of organ donors is increasing, an increase in transplant procedures is bound to happen. However, due to costlier procedure the market shift is expected to occur in Asian countries where medical tourism is being promoted.

Kidney Transplant Performed Analysis: United States is the leading kidney transplant performed with more than 40% share in 2015. The number of Kidney transplant done in 10 countries covered in the report was more than 40 Thousand in 2015. Brazil is the second leading kidney transplant performed country with more than 10% share. United Kingdom stands at the 3rd position in kidney transplant number. France and Mexico stand at the 4th and 5th place respectively in 2015.

Kidney Transplant Market Analysis: United States is the leading market for kidney transplant in 10 countries covered being followed by France. Spain stands at the 3rd position followed by Germany. Japan and Italy are competing very closely with each other to capture the maximum market share.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides the number of kidney transplant, as well as market and market shares of Kidney Transplant market. The report entails major organ transplant (immunosuppressant) drug sales analysis. This report also covers key development, drivers and challenges of Kidney Transplant market.

The 10 countries covered in the report are analysed from two viewpoints:

1. Number of Kidney Transplant Performed (2008 - 2021)
2. Kidney Transplant Market (2008 - 2021)

Based on geographical distribution, the Kidney Transplant market is categorized into following sub-markets:

1. United States
2. Germany
3. France
4. Italy
5. United Kingdom
6. Japan
7. Argentina
8. Mexico
9. Spain
10. Brazil

Organ Transplantation Immunosuppressive/Rejection Drugs Analysis in the report are as follows

1. Cellcept (Mycophenolate Mofetil)
2. Prograf(Tacrolimus)
3. Rapamune (Sirolimus)
4. Myfortic (Mycophenolic Acid)
5. Neoral / Sandimmune (Cyclosporine)
6. Zortress / Certican (Everolimus)

The report contains qualitative analysis, quantitative analysis and even regional analysis of major markets to cover all aspects of the Global Kidney Transplant market. You can use this report for investments or business strategies. Get in touch with Market Research Port today for the best price on the Global Kidney Transplant market research report.


  Table of Contents

1. Executive Summary

2. United States - Top Kidney Transplant Centres

3. 10 Major Markets - Kidney Transplant Number, Market Outlook
3.1 10 Major Markets - Kidney Transplant Number & Forecast
3.2 10 Major Markets - Kidney Transplant Market & Forecast

4. 10 Major Markets - Kidney Transplant Number, Market Share Outlook
4.1 Kidney Transplant Number Share & Forecast
4.2 Kidney Transplant Market Share & Forecast

5. Kidney Transplant Market – Top 10 Country Analysis (2008 – 2021) 
5.1 United States
5.1.1 United States – Number of Kidney Transplant & Forecast
5.1.2 United States – Kidney Transplant Market & Forecast
5.2 Germany
5.2.1 Germany – Number of Kidney Transplant & Forecast
5.2.2 Germany – Kidney Transplant Market & Forecast
5.3 France
5.3.1 France – Number of Kidney Transplant & Forecast
5.3.2 France – Kidney Transplant Market & Forecast
5.4 Italy
5.4.1 Italy – Number of Kidney Transplant & Forecast
5.4.2 Italy – Kidney Transplant Market & Forecast
5.5 United Kingdom
5.5.1 United Kingdom – Number of Kidney Transplant & Forecast
5.5.2 United Kingdom – Kidney Transplant Market & Forecast
5.6 Japan
5.6.1 Japan – Number of Kidney Transplant & Forecast
5.6.2 Japan – Kidney Transplant Market & Forecast
5.7 Argentina
5.7.1 Argentina – Number of Kidney Transplant & Forecast
5.7.2 Argentina – Kidney Transplant Market & Forecast
5.8 Mexico
5.8.1 Mexico – Number of Kidney Transplant & Forecast
5.8.2 Mexico – Kidney Transplant Market & Forecast
5.9 Spain
5.9.1 Spain – Number of Kidney Transplant & Forecast
5.9.2 Spain – Kidney Transplant Market & Forecast
5.10 Brazil – Kidney Transplant Market & Forecast
5.10.1 Brazil – Number of Kidney Transplant & Forecast
5.10.2 Brazil Kidney Transplant Market & Forecast

6. Key Development in Kidney Transplant Market
6.1 Year 2016

7. Organ Transplantation Immunosuppressive/Rejection Drugs Analysis
7.1 Cellcept (Mycophenolate Mofetil) 
7.1.1 CellCept (Mycophenolate Mofetil) Drugs Sales & Forecast
7.2 Prograf(Tacrolimus) 
7.2.1 Prograf (Tacrolimus) Drug Sales & Forecast
7.3 Rapamune (Sirolimus) 
7.3.1 Rapamune (Sirolimus) Drug Sales & Forecast
7.4 Myfortic (Mycophenolic Acid) 
7.4.1 Myfortic (Mycophenolic Acid) Drug Sales & Forecast
7.5 Neoral / Sandimmune (Cyclosporine) 
7.5.1 Neoral / Sandimmune (Cyclosporine) Drug Sales & Forecast
7.6 Zortress / Certican (Everolimus) 
7.6.1 Zortress / Certican (Everolimus) Drug Sales & Forecast

8. Kidney Transplant Market – Growth Drivers

9. Kidney Transplant Market – Challenges

    
  List of Tables:

Table 3–1: Number of Kidney Transplant(Percent),2008 – 2015
Table 3–2: Forecast for Number of Kidney Transplant(Percent),2016 – 2021
Table 3–3: Kidney Transplant Market Share(Percent),2008 – 2015
Table 3–4:  Forecast for Kidney Transplant Market Share (Percent),2016 – 2021

List of Figures:

Figure 2 1: Number of Kidney Transplant(Number), 2008 – 2015
Figure 2 2: Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 2 3: Kidney Transplant Market (Million US$), 2008 – 2015
Figure 2 4: Forecast for Kidney Transplant Market (Million US$), 2016 – 2021

Figure 4 1: United States – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 2: United States – Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 3: United States – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 4:United States – Forecast for Kidney Transplant Market (Million US$), 2016 – 2021
Figure 4 5: Germany – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 6: Germany – Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 7: Germany – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 8: Germany – Forecast for Kidney Transplant Market (Million US$), 2016 – 2021
Figure 4 9: France – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 10: France – Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 11: France – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 12: France – Forecast for Kidney Transplant Market (Million US$), 2016 – 2021
Figure 4 13: Italy – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 14: Italy – Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 15: Italy – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 16: Italy – Forecast for Kidney Transplant Market (Million US$), 2016 – 2021
Figure 4 17: United Kingdom – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 18: United Kingdom – Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 19: United Kingdom – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 20: United Kingdom – Forecast for Kidney Transplant Market (Million US$), 2016 – 2021
Figure 4 21: Japan – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 22: Japan – Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 23: Japan – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 24: Japan – Forecast for Kidney Transplant Market (Million US$), 2016 – 2021
Figure 4 25: Argentina – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 26: Argentina – Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 27: Argentina – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 28: Argentina – Forecast for Kidney Transplant Market (Million US$), 2016 – 2021
Figure 4 29: Mexico – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 30: Mexico – Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 31: Mexico – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 32: Mexico – Forecast for Kidney Transplant Market (Million US$), 2016 – 2021
Figure  4 33: Spain – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 34: Spain – Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 35: Spain – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 36: – Spain –  Forecast for Kidney Transplant Market (Million US$), 2016 – 2021
Figure 4 37: Brazil – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 38: – Brazil Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 39: Brazil – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 40: – Brazil –  Forecast for Kidney Transplant Market (Million US$), 2016 – 2021

Figure 5 1: Worldwide – CellCept Drug Sales (Million US$), 2008 – 2015
Figure 5 2: Worldwide – Forecast for CellCept Drug Sales (Million US$), 2016 – 2021
Figure 5 3: Worldwide – Prograf Drug Sales (Million US$), 2009 – 2015
Figure 5 4: Worldwide – Forecast for Prograf Drug Sales (Million US$), 2016 – 2021
Figure 5 5: Worldwide – Rapamune Drug Sales (Million US$), 2009 – 2015
Figure 5 6: Worldwide – Forecast for Rapamune Drug Sales (Million US$), 2016 – 2021
Figure 5 7: Worldwide – Myfortic Drug Sales (Million US$), 2008 – 2015
Figure 5 8: Worldwide – Forecast for Myfortic Drug Sales (Million US$), 2016 – 2021
Figure 5 9: Worldwide – Neoral / Sandimmune Drug Sales (Million US$), 2008 – 2015
Figure 5 10: Worldwide – Neoral / Sandimmune Drug Sales (Million US$), 2016 – 2021
Figure 5 11: Worldwide – Zortress/Certican Drug Sales (Million US$), 2008 – 2015
Figure 5 12: Worldwide – Forecast for Zortress / Certican Drug Sales (Million US$), 2016 – 2021

Figure 9 1: United States – Number of Kidney Living Donor (Number), 2011 – 2015

Kidney Transplant Market by Country (United States, Germany, France, Italy, United Kingdom, Japan, Argentina, Mexico, Spain, Brazil) Analysis and Forecast to 2021

Related Reports

Report Overview:

Life Science Consulting Services Market Overview

Healthcare Digital Twin Market Overview

Select Option

Related Reports

Clients